Due to COVID-19, HCA’s lobby is closed until further notice. Learn more about your virtual customer service options.

" "

Distributing opioid overdose reversal medications (2SSB 5195)

2SSB 5195 helps to increase access to naloxone for all individuals at risk of an opioid overdose. The law requires hospital emergency departments (EDs) and many certified and licensed behavioral health settings to distribute prepackaged naloxone to individuals at risk of an opioid overdose.

Education materials

Toolkits

Webinars

Contact

For training, consultation, educational materials, and implementation questions
Laura Meader, MA, LSWAIC
Overdose reversal medication program director
Email:
 laura.meader@hca.wa.gov

For billing and pharmacy questions
Email:
 Applehealthpharmacypolicy@hca.wa.gov